Narrow search
Showing 1 - 10 of 21,611
Cover Image
Tobacco culture in foreign countries
1889
Persistent link: https://www.econbiz.de/10003256687
Cover Image
France's pharmaceutical industry in global value chains
Cezar, Rafael - In: Banque de France bulletin / Quarterly selection of articles 44 (2016/2017), pp. 51-63
Persistent link: https://www.econbiz.de/10011643971
Cover Image
Reorganizing value chains through foreign direct investment : Austria's pharmaceutical industry international expansion
Zeller, Christian; Hametner, Andreas - In: Competition & change : the journal of global business … 22 (2018) 5, pp. 529-557
Persistent link: https://www.econbiz.de/10011940917
Cover Image
Inward foreign direct investment and patent rights : empirical evidence from OECD and nonOECD countries
Wagh, Smita - 2003
Persistent link: https://www.econbiz.de/10003386128
Cover Image
Foreign direct investment spillovers and pharmaceutical innovation : the role of intellectual property rights
Ho, Chun-Yu; Li, Xin; Zhou, Weimin - 2017
's accession to the World Trade Organization) (WTO) in 2001. We also show that there is a positive upstream spillover effect of FDI …
Persistent link: https://www.econbiz.de/10011723712
Cover Image
Strategies for internationalisation in pharma
Cayssials, Jean-Luc; Ranvier, Martial - In: Banque de France bulletin / Quarterly selection of articles 42 (2016), pp. 25-40
Persistent link: https://www.econbiz.de/10011522265
Cover Image
The food economy of today and tomorrow
Bunte, Frank - In: The food economy : global issues and challenges, (pp. 43-60). 2009
Persistent link: https://www.econbiz.de/10003868280
Cover Image
Globalisation in agriculture and food : the role of multinational enterprises
Scoppola, Margherita - In: European review of agricultural economics 48 (2021) 4, pp. 741-784
Persistent link: https://www.econbiz.de/10012618789
Cover Image
Pharmaceutical Patents and Expropriation in Indian Bilateral Investment Treaties
Ranjan, Prabhash - 2017
This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India's regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory measures such as compulsory licensing of pharmaceutical...
Persistent link: https://www.econbiz.de/10012959457